| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 12675703
[patent_doc_number] => 20180117067
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-03
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING PANCREATITIS
[patent_app_type] => utility
[patent_app_number] => 15/563304
[patent_app_country] => US
[patent_app_date] => 2016-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8412
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15563304
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/563304 | Methods and compositions for treating pancreatitis | Mar 29, 2016 | Issued |
Array
(
[id] => 12857890
[patent_doc_number] => 20180177804
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-28
[patent_title] => Scalable Vitamin Composition Unit Dosage for the Treatment of Fat-Soluble Vitamin Deficiences
[patent_app_type] => utility
[patent_app_number] => 15/558622
[patent_app_country] => US
[patent_app_date] => 2016-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5121
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15558622
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/558622 | Scalable vitamin composition unit dosage for the treatment of fat-soluble vitamin deficiencies | Mar 17, 2016 | Issued |
Array
(
[id] => 11895170
[patent_doc_number] => 09765095
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-19
[patent_title] => 'Easily synthesizable, spontaneously water-soluble, essentially voc-free, environmentally friendly (meth)acrylamido-functional siloxanol systems, process for preparation thereof and use'
[patent_app_type] => utility
[patent_app_number] => 15/070417
[patent_app_country] => US
[patent_app_date] => 2016-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9179
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15070417
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/070417 | Easily synthesizable, spontaneously water-soluble, essentially voc-free, environmentally friendly (meth)acrylamido-functional siloxanol systems, process for preparation thereof and use | Mar 14, 2016 | Issued |
Array
(
[id] => 12562434
[patent_doc_number] => 10016379
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-10
[patent_title] => Method of treatment for third spacing
[patent_app_type] => utility
[patent_app_number] => 15/066258
[patent_app_country] => US
[patent_app_date] => 2016-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 5659
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15066258
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/066258 | Method of treatment for third spacing | Mar 9, 2016 | Issued |
Array
(
[id] => 12857740
[patent_doc_number] => 20180177754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-28
[patent_title] => COMPOSITIONS FOR USE IN TREATING PULMONARY ARTERIAL HYPERTENSION
[patent_app_type] => utility
[patent_app_number] => 15/556607
[patent_app_country] => US
[patent_app_date] => 2016-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 82421
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15556607
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/556607 | Compositions for use in treating pulmonary arterial hypertension | Mar 8, 2016 | Issued |
Array
(
[id] => 12185441
[patent_doc_number] => 20180044378
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-15
[patent_title] => 'PROCESSES FOR PREPARING PHARMACEUTICALLY RELEVANT PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 15/555494
[patent_app_country] => US
[patent_app_date] => 2016-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29737
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15555494
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/555494 | Processes for preparing pharmaceutically relevant peptides | Mar 6, 2016 | Issued |
Array
(
[id] => 10978889
[patent_doc_number] => 20160175831
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-23
[patent_title] => 'CATALYSTS'
[patent_app_type] => utility
[patent_app_number] => 15/059036
[patent_app_country] => US
[patent_app_date] => 2016-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9126
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15059036
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/059036 | Catalysts | Mar 1, 2016 | Issued |
Array
(
[id] => 12238393
[patent_doc_number] => 20180071256
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATMENT AND PREVENTION OF PYREXIA IN HORSES'
[patent_app_type] => utility
[patent_app_number] => 15/554568
[patent_app_country] => US
[patent_app_date] => 2016-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7023
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15554568
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/554568 | Compositions and methods for treatment and prevention of pyrexia in horses | Mar 1, 2016 | Issued |
Array
(
[id] => 16381929
[patent_doc_number] => 10806739
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-20
[patent_title] => Use of n-desmethylclobazam in the treatment of chronic pain disorders and related methods
[patent_app_type] => utility
[patent_app_number] => 15/555227
[patent_app_country] => US
[patent_app_date] => 2016-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 6587
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15555227
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/555227 | Use of n-desmethylclobazam in the treatment of chronic pain disorders and related methods | Mar 1, 2016 | Issued |
Array
(
[id] => 11046140
[patent_doc_number] => 20160243098
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-25
[patent_title] => 'USE OF PRIDOPIDINE TO IMPROVE COGNITIVE FUNCTION AND FOR TREATING ALZHEIMER\'S DISEASE'
[patent_app_type] => utility
[patent_app_number] => 15/052368
[patent_app_country] => US
[patent_app_date] => 2016-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12875
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15052368
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/052368 | Use of pridopidine to improve cognitive function and for treating Alzheimer's disease | Feb 23, 2016 | Issued |
Array
(
[id] => 15481201
[patent_doc_number] => 10555926
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-11
[patent_title] => Use of cabazitaxel in the treatment of prostate cancer
[patent_app_type] => utility
[patent_app_number] => 15/551708
[patent_app_country] => US
[patent_app_date] => 2016-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 11
[patent_no_of_words] => 13832
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15551708
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/551708 | Use of cabazitaxel in the treatment of prostate cancer | Feb 16, 2016 | Issued |
Array
(
[id] => 11038780
[patent_doc_number] => 20160235734
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-18
[patent_title] => 'COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 15/040382
[patent_app_country] => US
[patent_app_date] => 2016-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 77547
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15040382
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/040382 | Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity | Feb 9, 2016 | Issued |
Array
(
[id] => 11205042
[patent_doc_number] => 09434660
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-06
[patent_title] => 'Methods for preparation of lycopenes from C15-wittig salts and methods for purification of high all-E containing and high 6Z containing C15-wittig salts'
[patent_app_type] => utility
[patent_app_number] => 15/009114
[patent_app_country] => US
[patent_app_date] => 2016-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4254
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15009114
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/009114 | Methods for preparation of lycopenes from C15-wittig salts and methods for purification of high all-E containing and high 6Z containing C15-wittig salts | Jan 27, 2016 | Issued |
Array
(
[id] => 12364116
[patent_doc_number] => 09956232
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-01
[patent_title] => Dialkyl-phosphinoyl-alkane (Dapa) compounds and compositions for treatment of lower gastrointestinal tract disorders
[patent_app_type] => utility
[patent_app_number] => 14/998458
[patent_app_country] => US
[patent_app_date] => 2016-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12044
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14998458
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/998458 | Dialkyl-phosphinoyl-alkane (Dapa) compounds and compositions for treatment of lower gastrointestinal tract disorders | Jan 5, 2016 | Issued |
Array
(
[id] => 10996425
[patent_doc_number] => 20160193371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-07
[patent_title] => 'CONJUGATES FOR IMAGING'
[patent_app_type] => utility
[patent_app_number] => 14/989498
[patent_app_country] => US
[patent_app_date] => 2016-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4505
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14989498
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/989498 | Conjugates for imaging | Jan 5, 2016 | Issued |
Array
(
[id] => 16229407
[patent_doc_number] => 10736937
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-11
[patent_title] => Methods and pharmaceutical compositions for the treatment of bacterial superinfections post-influenza
[patent_app_type] => utility
[patent_app_number] => 15/537596
[patent_app_country] => US
[patent_app_date] => 2015-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7251
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15537596
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/537596 | Methods and pharmaceutical compositions for the treatment of bacterial superinfections post-influenza | Dec 21, 2015 | Issued |
Array
(
[id] => 16183533
[patent_doc_number] => 10716826
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-21
[patent_title] => Compositions for overcoming anti-cancer drug-resistance or compositions for anti-cancer activity employing CAGE-derived peptides
[patent_app_type] => utility
[patent_app_number] => 14/978256
[patent_app_country] => US
[patent_app_date] => 2015-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 21
[patent_no_of_words] => 4128
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14978256
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/978256 | Compositions for overcoming anti-cancer drug-resistance or compositions for anti-cancer activity employing CAGE-derived peptides | Dec 21, 2015 | Issued |
Array
(
[id] => 12205826
[patent_doc_number] => 20180051053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-22
[patent_title] => 'METHOD FOR OBTAINING PEPTIDE FRAGMENT FROM ANTIBODY BY PROTEASE DECOMPOSITION REACTION WITH RESTRICTED REACTION FIELD'
[patent_app_type] => utility
[patent_app_number] => 15/556812
[patent_app_country] => US
[patent_app_date] => 2015-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13843
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15556812
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/556812 | METHOD FOR OBTAINING PEPTIDE FRAGMENT FROM ANTIBODY BY PROTEASE DECOMPOSITION REACTION WITH RESTRICTED REACTION FIELD | Dec 17, 2015 | Abandoned |
Array
(
[id] => 12866368
[patent_doc_number] => 20180180631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-28
[patent_title] => PROTEINS OF THE WNT SIGNALING PATHWAY AND USES THEREOF IN THE DIAGNOSTIC AND TREATMENT OF HYPOPIGMENTATION DISORDERS
[patent_app_type] => utility
[patent_app_number] => 15/536332
[patent_app_country] => US
[patent_app_date] => 2015-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13526
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15536332
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/536332 | Proteins of the WNT signaling pathway and uses thereof in the diagnostic and treatment of hypopigmentation disorders | Dec 15, 2015 | Issued |
Array
(
[id] => 12808375
[patent_doc_number] => 20180161295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-14
[patent_title] => TREATMENT OF CLOSED HEAD INJURY AND HEMORRHAGIC STROKE WITH HBED
[patent_app_type] => utility
[patent_app_number] => 15/536113
[patent_app_country] => US
[patent_app_date] => 2015-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12983
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15536113
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/536113 | TREATMENT OF CLOSED HEAD INJURY AND HEMORRHAGIC STROKE WITH HBED | Dec 15, 2015 | Abandoned |